Recommended as Stock of the Week on April 6, 2026

Markel: The Berkshire Hathaway that nobody has on their radar

TickerMKL.NYSE
Recommended Price1889.77 USD
Current Price 1889.77 USD
Markel Corporation – stock chart

Scores at time of recommendation (April 6, 2026)

Leeway Score
66/100
Excellent
Business Rating
67/100
Excellent
Market-Fit Rating
67/100
Excellent
Cycle Rating
65/100
Fair

More about our scores in Help

5-year stock timeline

2026 Q2 (July 29, 2026)

Markel reported second-quarter 2026 results and filed Form 10-Q. Management continued to message that the 2025 reorganization and refocused strategy were producing results. Underwriting profitability improved and investment income rose. The company emphasized progress on capital returns via buybacks, and investor perception shifted toward appreciating operational stabilization and the benefits of the strategic refocus begun in 2025.

Operating revenues reached $4.0 billion for Q2 2026. Adjusted operating income totaled $436 million for Q2 2026, excluding market movements in the equity portfolio. Share repurchases amounted to $237 million in the quarter and $371 million year to date [1][4].

2026 Q1 (April 28, 2026)

Markel reported first-quarter 2026 results and filed Form 10-Q. Results showed continued recovery in adjusted operating income versus the prior year, reinforcing the narrative that underwriting and investment performance were stabilizing after prior years' reserve and business-mix work. Investors saw improved recurring earnings quality as a foundation for capital allocation through buybacks and dividends.

Adjusted operating income reached $498 million for Q1 2026, a 4% increase versus Q1 2025 [12].

2025

Strategic reorganization and divestitures occurred throughout the year, including the sale or transfer of certain renewal rights in Global Reinsurance and other portfolio changes. Large buyback activity began or accelerated in 2025 as capital allocation shifted to share repurchases.

2025 marked a turning point where management refocused Markel's operating footprint and capital allocation. Investors began to re-evaluate the company from a complex conglomerate toward a more streamlined insurance-centric compounder with active capital returns. Sentiment moved from uncertainty about legacy reserve issues toward cautious optimism as reorganization effects became visible.

Management disclosed that underwriting gross premium volume changes in 2026 excluded the effect of the 2025 sale of renewal rights. Share repurchase activity reported in 2026 referenced $371 million year to date, reflecting the buyback trend begun in 2025 [1].

2024

Markel reported 2024 full-year results and announced acquisitions. In June 2024 the company acquired 98% of Valor Environmental. In September 2024 it acquired a 68% stake in Educational Partners International (EPI). The company continued expanding non-insurance operating businesses while managing insurance underwriting.

Investors viewed Markel's diversification into specialty services—environmental services and education staffing—as part of a strategy to broaden fee-earning businesses outside core insurance. The company's shareholder letter and annual report framed 2024 as continued growth in revenues and an active M&A posture [2][10][11].

2023

Markel reported 2023 financial results showing underwriting results that included favorable and adverse reserve developments. The company disclosed significant reserve strengthening on certain lines covering accident years 2020–2022.

Market attention in 2023 focused on reserve development and prior accident-year trends. After earlier adverse developments the company had to strengthen reserves on impacted lines. Perception moved toward caution about prior years' loss trends while watching management's corrective actions.

Insurance segment results included $38.6 million of net favorable development on prior years' loss reserves, compared to $167.4 million favorable in 2022. The company disclosed significant strengthening of reserves on impacted lines and on accident years 2020–2022 in its 2023 filings and releases [6][15].

2022

Continued reserve reviews and reserve strengthening disclosures occurred for accident years including 2020–2022. Underwriting performance and reserve development remained a central theme in the company narrative and filings.

2022 showed larger favorable development than 2023. Later filings noted the company strengthened reserves for certain lines and accident years through 2022 disclosures [15][6].

2021

Markel navigated post-2020 pandemic insurance market conditions, reporting results and managing investment portfolio and underwriting actions. Capital allocation through dividends and opportunistic buybacks featured in investor communications.

In 2021 investors treated Markel as a long-term insurance compounder with a diversified set of businesses. Optimism about recovery in underwriting margins and investment income supported a compounder narrative, though with attention to balance-sheet conservatism given prior reserve volatility [15][11].

Key Points

From recommendation (April 6, 2026)

  • P/E ratio of 10.7x with earnings growth of 95% last year - that looks like a revaluation gap
  • Price-to-book value of 1.2x: historically favorable for a company with an 11.8% return on equity
  • Sales growth of almost 10% shows that the insurance business is picking up speed operationally
  • Share buybacks underway - at below book value this would simply be capital allocation at Buffett level
  • Expansion in US ocean freight business signals disciplined growth in niche markets

Investment Thesis

From recommendation (April 6, 2026)

Markel is a specialty insurer that has been operating according to the same playbook for decades: disciplined underwriting in complex niche markets, combined with a long-term oriented investment portfolio. CEO Tom Gayner has managed the company since 1990 and has consistently increased the book value per share over this period. The model works because float from the insurance business serves as cheap capital for investments - a mechanism that has made Berkshire Hathaway great. The share is currently trading at a price-to-book ratio of 1.2x, which is unusually moderate for the quality of the company. Anyone with staying power and looking for quality at a reasonable price will find an easy-to-understand business model with a proven track record here.

Key risks and downside factors

Markel operates as a specialty property and casualty insurer and investment-focused holding company. It competes across two distinct channels: specialty P&C insurers on one side and larger diversified insurers that control capital and distribution networks in specialty, reinsurance, and program markets on the other. The competitive landscape centers on underwriting cycles and pricing pressure from established players—Berkshire Hathaway, Arch, Chubb, and W. R. Berkley among them—alongside more agile excess and surplus specialists like Kinsale and RLI. The company faces material risks from underwriting volatility and catastrophic losses, market fluctuations in its investment portfolio, competition for reinsurance capacity that could affect its capital position and ratings, and regulatory or tax shifts that could reshape both its insurance operations and holding-company structure.

  • Underwriting and catastrophic loss volatility present a genuine constraint. Large catastrophe events or concentrated specialty losses can materially compress combined ratios and erode surplus [8], [3].
  • Investment and market risk can reduce both investment income and the book value that supports underwriting through mark-to-market losses, rising interest rates, or credit defaults.
  • Capital competition and ratings pressure create real constraints. When capital becomes scarce, ratings face downgrade risk, or larger competitors deploy superior balance sheets, smaller players often find themselves forced to cut rates or accept slower growth.
  • Regulatory, tax, and litigation risk stem from shifts in insurance regulation, taxation approaches, or adverse litigation outcomes and reserve development across specialty lines—each capable of raising operational costs and capital requirements.

Competitive landscape

Markel Corporation operates as a specialty insurer and investment-oriented holding company, with primary exposure to specialty commercial property and casualty, excess and surplus lines, program business, and reinsurance. Its competitive set includes other specialty-focused and diversified insurers that maintain strong underwriting platforms and substantial investment float, alongside Lloyd's syndicates, managing general agents, and alternative capital providers. The company faces material risks from underwriting volatility driven by catastrophic events and pricing cycles, potential investment portfolio deterioration or insufficient returns, competitive pressure and channel disintermediation from managing general agents and insurtech platforms, and regulatory or capital adequacy changes that could restrict growth or necessitate additional capital raises.

Private competitors

  • Multiple managing general agents (MGAs) and specialty program administrators
  • Large private reinsurers/alternative capital vehicles (private equity-backed syndicates and funds)

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Catalysts

From recommendation (April 6, 2026)

  • Continuation of share buybacks at current valuation levels strengthens the book value per share
  • Further premium growth in the specialty insurance segment, particularly in the newly expanded US freight business
  • Positive development of the investment portfolio with stable or falling interest rates
  • Increasing the operating margin in the insurance business through disciplined underwriting in market phases
  • Possible revaluation by the market if there is a renewed focus on book value growth

Analysis

From recommendation (April 6, 2026)

Tom Gayner has been with the company since 1990 and embodies what investors value about Markel: Continuity, discipline and the ability to manage both the insurance and investment business with care. This is reflected in a return on equity of 11.8% and profit growth of 95% in the 2025 financial year - even if the latter is likely to be partly influenced by valuation effects in the investment portfolio and should not be interpreted as a continuous run. On the insurance side, Markel deliberately operates in markets where specialist knowledge represents a real barrier to entry: Niche products such as ocean freight, horse insurance or complex liability risks are not commodities. The expansion of the US ocean freight business with an experienced AIG veteran shows that Markel is growing organically without sacrificing underwriting discipline. The company is no stranger to regulation - insurance is a highly regulated business - but Markel has proven over decades that it can navigate these framework conditions with aplomb. In addition, Markel Ventures is an operating division beyond insurance that offers additional diversification. Analysts have recently adjusted their valuation models slightly upwards, while Brean Capital is pointing to valuation risks with a neutral rating - a healthy indication that the story is not without risk, but not a warning signal either.

Performance Figures of Markel Corporation

in USD

1M High / Low
1849.11 / 1712.45
52W High / Low
2207.59 / 1712.45
5Y High / Low
2207.59 / 1064.09
1M
-5.02%
3M
-13.50%
6M
-9.82%
1Y
-10.41%
3Y
+16.30%
5Y
+42.48%

Relative Performance vs Benchmarks

PeriodMarkel Corporation vs DAX vs S&P 500 (SPY)
1M -5.02% -0.99% -4.90%
3M -13.50% -12.01% -16.36%
6M -9.82% -18.59% -26.93%
1Y -10.41% -15.93% -26.36%
3Y +16.30% -47.47% -69.07%
5Y +42.48% -23.78% -45.68%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current8.41.11.08.3
1Y ago11.71.51.49.4
3Y ago9.81.31.47.1
5Y ago6.81.31.27.9

Frequently Asked Questions

From recommendation (April 6, 2026)

Is Markel Corporation a good investment?

Markel Corporation has a Leeway Score of 66.1/100, which is rated as Excellent. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.

What does Markel Corporation do?

Markel Corporation is a company characterized by the following investment thesis: Markel Group Inc. engages in the insurance business in the United States, the United Kingdom, Bermuda, Germany, rest of the European Union, Canada, and the Asia Pacific. It operates through Markel Insurance, Industrial, Financial, and Consumer and Other segments. The company offers general and professional liability, specialty programs, workers' compensation, and marine and energy insurance; personal lines insurance, such as property coverage for homeowners; property insurance coverages, including fire, windstorm, hail, water damage, and catastrophe-exposed property risks, such as earthquake and wind; and credit and surety products. It also distributes exterior building products, such as siding, windows, doors, roofing, and gutters; invests in asset and wealth management companies; engages in the homebuilding of single-family homes, townhouses, and condominiums; designs and provides leather handbags and accessories; owns and operates manufactured housing communities; and sponsors teachers for placement. In addition, the company offers structural and architectural precast concrete; ornamental plants; industrial bakery equipment; over-the-road car-hauling equipment, such as trailers; cutter suction and auger dredges; and laminated oak and composite flooring for trailers. Further, it provides fire protection, life safety, and low-voltage solutions; heavy lift crawler cranes; erosion control and stormwater management; gas containment and transportation equipment; wall panel systems and dorm room furniture; insurance-linked securities investment and insurance management; equipment leasing; fronting and automobile collateral protection coverage; information technology consulting; data collection and pricing intelligence solutions; and concierge healthcare membership services. The company was formerly known as Markel Corporation and changed its name to Markel Group Inc. in May 2023. Markel Group Inc. was founded in 1930 and is headquartered in Glen Allen, Virginia. Markel Corporation operates in the Financial Services / Insurance - Property & Casualty industry is based in USA employs around 22,900 people. Markel Corporation recently reported revenue of about 16.60B USD, a profit margin of 13.77%, return on equity of 12.46%, a market capitalisation around 21.56B USD, valuation multiples of roughly 9.5x earnings, 1.3x sales, 1.1x book value. Analyst consensus currently expects earnings per share of around 112.94 USD with year‑over‑year growth of 20.04%.

What are the key metrics for MKL.NYSE?

Key metrics for MKL.NYSE include valuation (P/E 10.7, P/S 1.4, P/B 1.2), profitability (profit margin 12.70%, ROE 11.77%), and growth (revenue 9.90%, earnings 95.40%). Market capitalization is 22.47B USD. These metrics give an overview of the company's financial performance and valuation.

How has Markel Corporation's stock price performed?

Markel Corporation's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

How is MKL.NYSE valued?

MKL.NYSE has the following valuation metrics: P/E Ratio: 10.7, P/S Ratio: 1.4, P/B Ratio: 1.2. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the growth catalysts for Markel Corporation?

The key growth catalysts for Markel Corporation are:
  • Continuation of share buybacks at current valuation levels strengthens the book value per share
  • Further premium growth in the specialty insurance segment, particularly in the newly expanded US freight business
  • Positive development of the investment portfolio with stable or falling interest rates
  • Increasing the operating margin in the insurance business through disciplined underwriting in market phases
  • Possible revaluation by the market if there is a renewed focus on book value growth
These factors can positively influence the company's future growth and performance.

What are the key risks when investing in MKL.NYSE?

Key risks for MKL.NYSE include: Markel operates as a specialty property and casualty insurer and investment-focused holding company. It competes across two distinct channels: specialty P&C insurers on one side and larger diversified insurers that control capital and distribution networks in specialty, reinsurance, and program markets on the other. The competitive landscape centers on underwriting cycles and pricing pressure from established players—Berkshire Hathaway, Arch, Chubb, and W. R. Berkley among them—alongside more agile excess and surplus specialists like Kinsale and RLI. The company faces material risks from underwriting volatility and catastrophic losses, market fluctuations in its investment portfolio, competition for reinsurance capacity that could affect its capital position and ratings, and regulatory or tax shifts that could reshape both its insurance operations and holding-company structure.
  • Underwriting and catastrophic loss volatility present a genuine constraint. Large catastrophe events or concentrated specialty losses can materially compress combined ratios and erode surplus [8, 3, 21].
  • Investment and market risk can reduce both investment income and the book value that supports underwriting through mark-to-market losses, rising interest rates, or credit defaults.
  • Capital competition and ratings pressure create real constraints. When capital becomes scarce, ratings face downgrade risk, or larger competitors deploy superior balance sheets, smaller players often find themselves forced to cut rates or accept slower growth.
  • Regulatory, tax, and litigation risk stem from shifts in insurance regulation, taxation approaches, or adverse litigation outcomes and reserve development across specialty lines—each capable of raising operational costs and capital requirements.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Markel Corporation?

Markel Corporation competes with several listed peers in its sector. Markel Corporation operates as a specialty insurer and investment-oriented holding company, with primary exposure to specialty commercial property and casualty, excess and surplus lines, program business, and reinsurance. Its competitive set includes other specialty-focused and diversified insurers that maintain strong underwriting platforms and substantial investment float, alongside Lloyd's syndicates, managing general agents, and alternative capital providers. The company faces material risks from underwriting volatility driven by catastrophic events and pricing cycles, potential investment portfolio deterioration or insufficient returns, competitive pressure and channel disintermediation from managing general agents and insurtech platforms, and regulatory or capital adequacy changes that could restrict growth or necessitate additional capital raises.
  • Chubb Limited (CB.NYSE)
  • The Travelers Companies, Inc. (TRV.NYSE)
  • W. R. Berkley Corporation (WRB.NYSE)
  • AXIS Capital Holdings Limited (AXS.NYSE)
  • RenaissanceRe Holdings Ltd. (RNR.NYSE)
  • RLI Corp. (RLI.NYSE)
  • Kinsale Capital Group, Inc. (KNSL.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

When does Markel Corporation report earnings?

Markel Corporation's next earnings report date is November 4, 2026.

Key Metrics

From recommendation (April 6, 2026)

Market Capitalization
22.47B USD
P/E Ratio
10.66
Analyst Target Price
2085.40 USD

Valuation Metrics

P/S Ratio
1.38
P/B Ratio
1.21

Profitability Metrics

Profit Margin
12.70%
Operating Margin
18.84%
Return on Equity
11.77%
Return on Assets
3.05%

Growth Metrics

Revenue Growth
9.90%
Earnings Growth
95.40%

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

No dividend data available.

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

59.8%
Beat estimate
39.3%
Miss estimate
+44.52%
Avg surprise when beat
-166.63%
Avg surprise when miss

Reports analyzed: 122

Upcoming earnings report

November 4, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus112.94
Range85.69 – 129.41
6 analysts
Est. growth vs prior: 20.04%
Revisions: 7d ↑0 ↓0 · 30d ↑1 ↓4

Key financial figures

All figures in USD

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue16.59B16.75B15.71B11.81B12.92B
Operating income (EBIT)2.73B3.64B2.65B-151.57M3.13B
Net income2.11B2.75B2.00B-216.28M2.42B
Free cash flow2.55B2.34B2.53B2.45B2.13B
Total assets68.91B47.35B43.44B63.44B48.48B
Equity18.60B16.92B14.98B37.90B14.72B
Net debt339.11M1.45B636.35M-33.80M844.15M
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon